Targeted ligand-payload based drug delivery for cell therapy
NZ797259BActive Publication Date: 2026-09-01PURDUE RES FOUND
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- NZ797259
- Authority / Receiving Office
- NZ · NZ
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-02-17
- Filing Date
- 2018-02-17
- Publication Date
- 2026-09-01
- Estimated Expiration
- 2038-02-17
Smart Images
Figure 00000024_0000 
Figure 00000027_0000 
Figure 00000045_0000
Abstract
A drug delivery platform providing flexible fine tune of cell therapy is disclosed herein. Particularly, an engineered fusion protein is coupled with a high affinity ligand carrying at least one payload of drug to be internalized by the transplanted cell to observe or regulate transplanted cell therapy effects.
Need to check novelty before this filing date? Find Prior Art